6.65
0.00%
0.00
Handel nachbörslich:
6.62
-0.03
-0.45%
Finanzdaten der Voyager Therapeutics Inc-Aktie (VYGR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
78.33%
19.52
|
90.06 | 4.614 | 4.853 | 150.48 |
Operating Expenses
|
0.83%
35.70
|
36.00 | 34.12 | 30.28 | 27.60 |
Benefits Costs and Expenses |
6.13%
30.83
|
32.84 | 30.69 | 27.00 | 25.73 |
Costs And Expenses |
6.13%
30.83
|
32.84 | 30.69 | 27.00 | 25.73 |
Operating Income/Loss |
129.93%
-16.18
|
54.06 | -29.51 | -25.43 | 122.88 |
Nonoperating Income/Loss |
54.31%
4.867
|
3.154 | 3.429 | 3.277 | 1.864 |
Income/Loss From Continuing Operations Before Tax |
119.78%
-11.32
|
57.22 | -26.08 | -22.15 | 124.75 |
Income Tax Expense/Benefit |
98.30%
0.014
|
0.822 | -0.177 | 0.059 | 0.704 |
Income/Loss From Continuing Operations After Tax |
120.09%
-11.33
|
56.40 | -25.90 | -22.21 | 124.04 |
Net Income/Loss
|
120.09%
-11.33
|
56.40 | -25.90 | -22.21 | 124.04 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,675%
57.12
|
2.0586 | 43.86 | 43.52 | 40.63 |
Diluted Average Shares |
2,816%
57.12
|
1.9586 | 43.86 | 43.52 | 42.16 |
Basic Earnings Per Share |
116.26%
-0.20
|
1.23 | -0.59 | -0.51 | 3.05 |
Diluted Earnings Per Share |
116.81%
-0.20
|
1.19 | -0.59 | -0.51 | 2.94 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):